KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $19.65 $26.36 Friday, 26th Apr 2024 PRTA stock ended at $20.87. This is 1.51% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.13% from a day low at $20.34 to a day high of $21.18.
90 days $19.65 $33.84
52 weeks $19.65 $79.64

Historical Prothena Corporation plc prices

Date Open High Low Close Volume
Apr 26, 2024 $20.72 $21.18 $20.34 $20.87 363 287
Apr 25, 2024 $20.26 $20.67 $19.65 $20.56 474 266
Apr 24, 2024 $20.62 $20.88 $20.32 $20.56 335 370
Apr 23, 2024 $21.25 $21.70 $20.44 $20.56 419 434
Apr 22, 2024 $21.20 $21.77 $20.88 $21.29 331 377
Apr 19, 2024 $20.56 $21.18 $20.42 $21.16 495 825
Apr 18, 2024 $20.97 $21.26 $20.44 $20.57 552 117
Apr 17, 2024 $21.61 $21.70 $20.95 $21.00 461 582
Apr 16, 2024 $21.67 $22.14 $21.06 $21.34 472 815
Apr 15, 2024 $22.26 $22.44 $21.59 $21.99 511 865
Apr 12, 2024 $23.14 $23.30 $21.92 $22.24 514 370
Apr 11, 2024 $23.28 $23.99 $22.21 $23.28 574 321
Apr 10, 2024 $22.28 $22.93 $21.91 $22.82 512 554
Apr 09, 2024 $23.75 $24.08 $22.93 $23.54 460 892
Apr 08, 2024 $23.72 $24.07 $23.39 $23.68 283 371
Apr 05, 2024 $23.00 $23.82 $22.23 $23.37 462 483
Apr 04, 2024 $24.50 $25.12 $22.88 $23.26 741 921
Apr 03, 2024 $23.64 $24.36 $23.23 $24.26 598 152
Apr 02, 2024 $25.02 $25.36 $23.89 $23.95 756 595
Apr 01, 2024 $24.92 $26.36 $24.52 $26.15 603 413
Mar 28, 2024 $25.25 $25.34 $24.29 $24.77 773 086
Mar 27, 2024 $25.07 $25.57 $24.46 $25.16 597 050
Mar 26, 2024 $25.87 $25.87 $24.53 $24.75 593 991
Mar 25, 2024 $25.82 $26.27 $24.71 $25.40 373 714
Mar 22, 2024 $25.42 $26.37 $25.18 $25.92 931 541
Click to get the best stock tips daily for free!

About Prothena Corporation plc

Prothena  plc Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson's disease... PRTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT